Karine Lignel

Gründer bei ONCODESIGN PRECISION MEDICINE

58 Jahre

Health Technology

Finance

Consumer Services

Profil

Karine Lignel is the founder of Oncodesign Precision Medicine SA, founded in 2020, holding the titles of Chief Operating Officer, Director & Deputy MD.
Current jobs include Chairman at Société Financière Aquitaine De Participation; Investment Director at CM-CIC Innovation SASU since 2011; Director, Group Chief Development Officer & SVP at Oncodesign SA since 2021; and Director at SILIOS Technologies SA. Former jobs include Director at Ariana Pharmaceuticals SA, Amorçage Rhône-Alpes SAS as Investment Director, Sartorius Polyplus SAS, Confederation Nationale Crédit Mutuel SA, EndoControl SAS, ImmunID SAS, e(ye) Brain SA, Tissium SA, Maat Pharma SA, Krono-Safe SA; Non-Voting Director at Voluntis SA; Director at Global Bioenergies SA from 2013 to 2020; Member-Supervisory Board at Coldway SA, Rhones Alpes Creation, Nanobiotix SA, MedinCell SA, and ForCity SAS. Education includes an MBA from ESSEC Business School and undergraduate studies at Ecole Superieure des Industries Agricoles et Alimentaires.

Aktive Positionen von Karine Lignel

Unternehmen	Position	Beginn
ONCODESIGN	Direktor/Vorstandsmitglied	14.05.2008
ONCODESIGN PRECISION MEDICINE	Gründer	15.12.2020
CM-CIC Innovation SASU CM-CIC Innovation SASU Investment ManagersFinance CM-CIC Innovation invests in companies located in France. The firm targets companies operating in deeptech, software & IT and health sectors. It provides financing for early stage transactions, It acts as a lead investor.	Director of Investments	08.12.2009
Société Financière Aquitaine De Participation Société Financière Aquitaine De Participation Financial ConglomeratesFinance Functions as an investment holding company	Vorsitzender	-
SILIOS Technologies SA SILIOS Technologies SA Electronic ComponentsElectronic Technology Manufactures optical miniature parts	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Karine Lignel

Ehemalige bekannte Positionen von Karine Lignel

Unternehmen	Position	Ende
GLOBAL BIOENERGIES SA	Direktor/Vorstandsmitglied	01.03.2020
NANOBIOTIX	Direktor/Vorstandsmitglied	-
Polyplus-transfection SA Polyplus-transfection SA BiotechnologyHealth Technology Provides cell and gene therapy services	Direktor/Vorstandsmitglied	-
ImmunID SAS ImmunID SAS Medical SpecialtiesHealth Technology Researches and develops diagnostic tools for monitoring immune cell repertoire	Direktor/Vorstandsmitglied	-
░░░░░░░ ░░	░░░░░░░░░░░░░░░░░░░░░░░░░░	-

Sehen Sie sich die Erfahrung von Karine Lignel im Detail an

Ausbildung von Karine Lignel

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Karine Lignel im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	24
Ariana Pharmaceuticals SA Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Provides pharmaceutical, clinical and data technology	Health Technology
ESSEC Business School ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
CM-CIC Innovation SASU CM-CIC Innovation SASU Investment ManagersFinance CM-CIC Innovation invests in companies located in France. The firm targets companies operating in deeptech, software & IT and health sectors. It provides financing for early stage transactions, It acts as a lead investor.	Finance
Amorçage Rhône-Alpes SAS Amorçage Rhône-Alpes SAS Investment ManagersFinance ARA is an active manager which invests in innovative French technology companies with high growth potential in a range of sectors including biotechnology, information technology and telecom, medical technology, nanotechnology and environment. The firm seeks to invest EUR 50,000-200,000 in companies which are either in their creation stage or have been in operation for less than two years, which are based in the administrative territory of the Rhone-Alpes region and which have technology originating from, or being developed in cooperation with a French public research institution. ARA usually co-invests with other financing partners and typically expects to exit their investments after three to seven years. The firm's investment committee makes the investment decisions.	Finance
Coldway SA Coldway SA Wholesale DistributorsDistribution Services Manufactures refrigerated and insulated containers	Distribution Services
Oncodesign SA Oncodesign SA BiotechnologyHealth Technology Develops preclinical evaluation of novel anticancer therapies	Health Technology
Polyplus-transfection SA Polyplus-transfection SA BiotechnologyHealth Technology Provides cell and gene therapy services	Health Technology
Confederation Nationale Crédit Mutuel SA Confederation Nationale Crédit Mutuel SA Major BanksFinance Provides cooperative banking services	Finance
Rhones Alpes Creation
EndoControl SAS EndoControl SAS Medical SpecialtiesHealth Technology Designs, develops and markets robotics solutions for laparoscopic surgeries	Health Technology
Nanobiotix SA Nanobiotix SA Pharmaceuticals: MajorHealth Technology Develops and manufactures nanotherapeutics for treatment of cancer	Health Technology
Ecole Superieure des Industries Agricoles et Alimentaires Ecole Superieure des Industries Agricoles et Alimentaires Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Voluntis SA Voluntis SA Packaged SoftwareTechnology Services Develops anti-cancer treatment platform	Technology Services
SILIOS Technologies SA SILIOS Technologies SA Electronic ComponentsElectronic Technology Manufactures optical miniature parts	Electronic Technology
ImmunID SAS ImmunID SAS Medical SpecialtiesHealth Technology Researches and develops diagnostic tools for monitoring immune cell repertoire	Health Technology
e(ye) Brain SA e(ye) Brain SA Medical DistributorsDistribution Services Provides medical research services	Distribution Services
Global Bioenergies SA Global Bioenergies SA Chemicals: SpecialtyProcess Industries Develops industrial processes to convert renewable sources into hydrocarbons through fermentation	Process Industries
MedinCell SA MedinCell SA Pharmaceuticals: MajorHealth Technology Provides therapeutic solutions	Health Technology
Krono-Safe SA Krono-Safe SA Packaged SoftwareTechnology Services Provides software solutions for the development of embedded systems	Technology Services
Tissium SA Tissium SA BiotechnologyHealth Technology Develops biomorphic and programmable polymers for tissue reconstruction	Health Technology
Maat Pharma SA Maat Pharma SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops and commercializes patient-microbiome symbiosis to improve survival outcomes in oncology	Health Technology
ForCity SAS ForCity SAS Miscellaneous Commercial ServicesCommercial Services Provides support services to the decision for the actors public and economic territories	Commercial Services
Société Financière Aquitaine De Participation Société Financière Aquitaine De Participation Financial ConglomeratesFinance Functions as an investment holding company	Finance
Oncodesign Precision Medicine SA Oncodesign Precision Medicine SA Pharmaceuticals: MajorHealth Technology Discovers and develops new molecules for the health treatments in oncology	Health Technology